![Dipal Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 604 691 $ al 31/05/2026
Dipal Patel is currently the Chief Commercial Officer at Valneva SE.
Previously, Dipal worked as the Head-Global Commercial at GSK Plc from 2019 to 2023.
Before that, Dipal held the position of Vice President-Vaccines Commercialization at GlaxoSmithKline GmbH & Co. KG.
Dipal completed an undergraduate degree at Macquarie University in 1998 and obtained an MBA from Macquarie Graduate School of Management Pty Ltd. in 2006.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VALNEVA SE 0,1 % | 31/12/2025 | 198.385 ( 0,1 % ) | 604 691 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VALNEVA SE | Corporate Officer/Principal | 17/11/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/02/2023 |
GlaxoSmithKline GmbH & Co. KG
 GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Macquarie University
 Macquarie University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Macquarie Graduate School of Management Pty Ltd.
 Macquarie Graduate School of Management Pty Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
